Navigation Links
No Link Between Coarse Air Pollution, Hospitalizations
Date:5/13/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Link Between Coarse Air Pollution, Hospitalizations
No Link Between Coarse Air Pollution, Hospitalizations
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...re receiving MMR shots, say official figures.// ... of two-year-olds were given the jab, which protec...the national target of 95 per cent. Yet, this i... previous year, when the figure was 89.9 per cent....
...s published in The Lancet on adolescent health, th...when compared to their parents.// The infections o...ve given way to venereal diseases, drinking, smoki...y silver lining to this issue is that these condit...
...e it worse. New research links them to three time... Claiming to be the world’s first such research, ...say that overweight girls triple their risk of dev... The findings published in the European Respirato...
...ed the aerated drink manufacturers Pepsico and Coc...ports.// The Ganguly report had deduced that pesti... from Pepsico and Coca cola should be furnished wi...rest, a civil society group had filed a public int...
Other Medicine News:Health News:Scotland’s Parents Still a Little Wary of MMR Shot 2Health News:Chubby Cute Little Girls- Not for the Health Conscious 2
(Date:7/22/2008)...is Technology in the European ...wswire-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYNO...d array of,light-based aesthetic treatment systems...MPX(TM), the company,s high-powered, dual-waveleng...n skin through collagen,remodeling. The CE Mark ce...
(Date:7/21/2008)... as consolidation therapy after remission inducti...r lymphoma, SEATTL...tics, Inc.,(CTI) (Nasdaq and MTA: CTIC) announced ...h the U.S. Food and Drug Administration (FDA) in S...pplemental Biologics License,Application (sBLA) fo...
(Date:7/21/2008)...008 conferences, GAITHERSBURG, Md., July 21 /PRNe...ompany developing gene therapies for HIV and genet...Phase I and Phase II,clinical trials for the media...an investigational gene therapy for the treatment ...day, July 24, 2008 at 11 a.m. EDT. The,presentatio...
(Date:7/21/2008)...h in Italy continue, FRANKLIN, Mass., July 21 /PR...C ) announced today that it will defer the commenc...TM) System in the prevention of,Contrast-Induced N... the,investigator-sponsored clinical trial now ong... launch of RenalGuard in Europe, which began in th...
Breaking Medicine Technology:Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5Statehouse Atrium to be Site for Childrens Dental Access Event Ohio Legislators to Mingle With Children and Dentists for This Free Care Event 21 9781 1Statehouse Atrium to be Site for Childrens Dental Access Event Ohio Legislators to Mingle With Children and Dentists for This Free Care Event 21 9781 2Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 1Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 2Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 3Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 1Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 2Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 3Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 1Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 2Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 3
... Rexahn,Pharmaceuticals, Inc. (OTC BB:RXHN), a bio... development, and commercialization of,innovative ...rders,sexual dysfunction and other unmet medical ...ncipal Investigator of Phase I clinical,trial of t...n),will present results of the clinical study at ...
...n Transplantation, HORSHOLM, Denmark, May 31, 2007...ces positive Phase I clinical results for,its tran...nto US,Phase II clinical trials for organ transpla...nounces positive results,from its Phase I clinical...aily tacrolimus tablet. , A series of Phase I tria...
Other Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: